Operating Lease, Right-of-Use Asset of BridgeBio Oncology Therapeutics, Inc. from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BridgeBio Oncology Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
  • BridgeBio Oncology Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $2,330,000.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)

BridgeBio Oncology Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,330,000 +$2,330,000 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 $2,440,000 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q4 2024 $0 31 Dec 2024 10-K 05 Mar 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.